HEMGENIX, the first and only FDA-approved gene therapy for Hemophilia B

CSL & BDAI will be holding a second HEMGENIX Gene Therapy Educational Webinar giving you the opportunity to learn about:

• HEMGENIX, the first and only gene therapy approved for Hemophilia B

• Gain insightful information and deepen your understanding of HEMGENIX through a LIVE Q&A Session

• Ask questions and gain new resources on gene therapy

SPEAKER: Guy Young, MD: Children’s Hospital Los Angeles, CA

Register in advance for this webinar:

https://us06web.zoom.us/webinar/register/WN_0AOj70dWQUa5tr6UoBa7kg